Your contact person
Manager PR & Communications Jan Phillip Denkers
Sysmex Europe SE is listed in the top 100 best workplaces
Sysmex Europe is proud to announce that Sysmex Europe SE is listed in the top 100 best workplaces by Great Place ...
Read more …
Indivumed Celebrates 20th Anniversary
Indivumed GmbH (“Indivumed”) today celebrated the company’s 20th anniversary milestone. Founded in Hamburg, Germany on April 5, 2002, Indivumed has rapidly expanded to ...
Read more …
LKF is a new member of Life Science Nord e.V.
For more than 30 years, LKF has been supporting research-based pharmaceutical companies and contract research organizations with laboratory services in the context of ...
Read more …
Sysmex Establishes Subsidiary in Saudi Arabia
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today the establishment of a new subsidiary, Sysmex LLC, in Saudi Arabia. With this ...
Read more …
Evotec and Lilly enter into collaboration
Evotec SE announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company (“Lilly”) in the ...
Read more …
Accelerated drug development and personalised treatments for cancer
Indivumed GmbH is a biotech company with international activities and representative offices in the US, Japan, Italy and Brasil. It cooperates with numerous international research ...
Read more …
Evotec: € 7.5 m grant for development of COVID-19 therapeutic
Evotec SE announced that the Company has been selected by the German Federal Ministry of Education and Research (“BMBF”) to receive a grant for the ...
Read more …
Evotec receives US$ 18 m grant for women's health
Evotec SE announced that the Company has received a US$ 18 m grant from the Bill & ...
Read more …
Quantum Physics in Proteins
A new analytical technique is able to provide hitherto unattainable insights into the extremely rapid dynamics of biomolecules. The team of developers, led by Abbas ...
Read more …
Evotec Initiates US IPO
Evotec expects to grant the underwriters a 30-day option to purchase up to an additional 3,300,000 ADSs. The sale of the ADSs and the issuance ...
Read more …
Eppendorf SE: conversion to European public limited company
"We are convinced that we have taken the right step at the right time with this modern legal form, which is very common in ...
Read more …
Evotec: Collaboration with Bristol Myers Squibb
Evotec SE announced that its collaboration with Bristol Myers Squibb has been expanded to include a new cell type, triggering a payment of $ 9.0 ...
Read more …